APA (7th ed.) Citation

Alleva, D. G., Maki, R. A., Putnam, A. L., Robinson, J. M., Kipnes, M. S., Dandona, P., . . . Gottlieb, P. A. (2006). Immunomodulation in Type 1 Diabetes by NBI-6024, an Altered Peptide Ligand of the Insulin B(9−23) Epitope. Scandinavian Journal of Immunology, 63(1), 59. https://doi.org/10.1111/j.1365-3083.2005.01705.x

Chicago Style (17th ed.) Citation

Alleva, D. G., et al. "Immunomodulation in Type 1 Diabetes by NBI-6024, an Altered Peptide Ligand of the Insulin B(9−23) Epitope." Scandinavian Journal of Immunology 63, no. 1 (2006): 59. https://doi.org/10.1111/j.1365-3083.2005.01705.x.

MLA (9th ed.) Citation

Alleva, D. G., et al. "Immunomodulation in Type 1 Diabetes by NBI-6024, an Altered Peptide Ligand of the Insulin B(9−23) Epitope." Scandinavian Journal of Immunology, vol. 63, no. 1, 2006, p. 59, https://doi.org/10.1111/j.1365-3083.2005.01705.x.